C07J 19/005
Glycosides
Official title: {Glycosides}
C07J19/005 (Glycosides) appears on 54 US grants and 23 published applications in this corpus.
Search patents in C07J- Granted patents
- 54
- Published applications
- 23
- Assignees
- 49
- Inventors
- 142
- Latest grant
- 9 Dec 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 8 | 0 |
| 1977 | 7 | 0 |
| 1978 | 3 | 0 |
| 1979 | 1 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 2 | 0 |
| 1983 | 1 | 0 |
| 1984 | 2 | 0 |
| 1985 | 0 | 0 |
| 1986 | 2 | 0 |
| 1987 | 0 | 0 |
| 1988 | 2 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 3 | 0 |
| 1992 | 2 | 0 |
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 1 | 0 |
| 1996 | 0 | 0 |
| 1997 | 1 | 0 |
| 1998 | 2 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 2 |
| 2004 | 2 | 0 |
| 2005 | 0 | 2 |
| 2006 | 1 | 0 |
| 2007 | 1 | 1 |
| 2008 | 0 | 1 |
| 2009 | 1 | 1 |
| 2010 | 0 | 1 |
| 2011 | 0 | 1 |
| 2012 | 0 | 1 |
| 2013 | 1 | 2 |
| 2014 | 2 | 2 |
| 2015 | 0 | 0 |
| 2016 | 1 | 2 |
| 2017 | 1 | 0 |
| 2018 | 1 | 1 |
| 2019 | 0 | 0 |
| 2020 | 1 | 2 |
| 2021 | 2 | 1 |
| 2022 | 0 | 1 |
| 2023 | 1 | 0 |
| 2024 | 0 | 2 |
| 2025 | 1 | 0 |
By publication year. Applications have been published since 2001.
Recent patents
- Inhibition of interaction between OCT4 and MAPKAPK2 or DNA-PKcs to regulate c-MYC in cancer9 Dec 2025US 12,491,191 B2Texas Tech University System
- 17beta-heterocyclyl-digitalis like compounds for the treatment of heart failure22 Aug 2023US 11,730,746 B2CVie Therapeutics Limited
- Crystal characteristics, preparation processes and anticancer applications of 17beta-neriifolin crystal forms17 Aug 2021US 11,091,510 B2Enkang Pharmaceuticals (Guangzhou), Ltd.
- Selective inhibitors of Alpha2-containing isoforms of Na,K-ATPase and use thereof for reduction of intraocular pressure3 Aug 2021US 11,077,128 B2Yeda Research and Development Co. Ltd.
- Selective inhibitors of Alpha2-containing isoforms of Na,K-ATPase and use thereof for reduction of intraocular pressure2 Jun 2020US 10,668,094 B2Yeda Research and Development Co. Ltd.
- Use of st-type lipid compounds in preparation of nucleic acid delivery reagent and related product5 Sep 2024US 2024/0293551 A1Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences
- Compounds for altering levels of one or more nka alpha subunits and their use in treating prion diseases or brain diseases associated with cellular prion protein23 May 2024US 2024/0166684 A1
- Inhibition of interaction between oct4 and mapkapk2 or dna-pkcs to regulate c-myc in cancer28 Jul 2022US 2022/0233554 A1Texas Tech University System
- 17beta-heterocyclyl-digitalis like compounds for the treatment of heart failure16 Sep 2021US 2021/0283147 A1CVie Therapeutics Limited
- Selective inhibitors of alpha2-containing isoforms of na,k-atpase and use thereof for reduction of intraocular pressure24 Sep 2020US 2020/0297748 A1Yeda Research and Development Co. Ltd.
Most cited
By later US patents
- Coupling agents and products produced therefrom24US 4,595,656 ABecton, Dickinson and Company · 1986
- Chemical process21US 4,082,747 AMallinckrodt Inc. · 1978
- Antidigoxin antibodies20US 4,767,720 AHSC Research Development Corporation · 1988
- Compounds that bind to digitalis receptor14US 5,144,017 AUniversity of Manitoba · 1992
- Diagnostic immunoassay by solid phase separation for digoxin12US 4,788,136 AAbbott Laboratories · 1988